Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company’s healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent f
| Current Price | ₹8,089.50 |
|---|---|
| Market Cap | ₹1,16,315 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 59.9 |
| Return on Equity | 21.50% |
| 52-Week Range | ₹6,696.50 – ₹8,443.00 |
| Beta (1Y) | 0.39 |
| Dividend Yield | 0.25% |
1. Healthcare Services-50.5% 2. Retail Health & Diagnostics-7.4% 3. Digital Health & Pharmacy Distribution-42.8% 4. Others-0%
Apollo Hospitals Enterprise Limited is trading at ₹8,089.50, with a market capitalisation of ₹1,16,315 Cr.
Apollo Hospitals Enterprise Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Apollo Hospitals Enterprise Limited has a P/E of 59.9 and a return on equity of 21.50%.